Previous 10 | Next 10 |
home / stock / rhhby / rhhby news
2023-12-04 08:26:05 ET More on EyePoint Pharma Shorting EyePoint Pharmaceuticals Ahead Of Davio-2 Wet-AMD Data: Potential 78% Gain Countdown To Clarity: EyePoint's December Data Delivery EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2023 Earnings Conference Call Transcrip...
2023-12-04 07:49:22 ET More on Absci, AstraZeneca, etc. AstraZeneca Pays Hefty Price For Chinese Weight-Loss Drug AstraZeneca PLC 2023 Q3 - Results - Earnings Call Presentation AstraZeneca PLC (AZN) Q3 2023 Earnings Call Transcript EU regulators seeking more ...
2023-12-04 05:44:22 ET Roche ( OTCQX:RHHBY ) announced on Monday a deal to acquire U.S. biotechnology company Carmot Therapeutics for USD 2.7B in cash at closing. Based in Berkeley, California, Carmot specializes in obesity drugs, with a broad pipeline of therapeutics, including thr...
2023-12-03 11:19:58 ET Summary Foreign stocks, particularly those with solid yields, are relatively cheap compared to the S&P 500. The Vanguard International High Dividend Yield Index Fund ETF Shares offers low valuation and solid long-term growth trends. VYMI has a high d...
2023-11-30 00:50:33 ET Summary Tweedy, Browne's 13F portfolio value decreased by 2% to $1.87B this quarter. The largest position in the portfolio is Berkshire Hathaway, followed by Alphabet, Johnson & Johnson, Ionis Pharma, and Coca-Cola FEMSA. Tweedy, Browne made new stak...
2023-11-29 13:38:43 ET More on Aeglea BioTherapeutics Aeglea Biotherapeutics announces name change to Spyre Therapeutics Aeglea BioTherapeutics announces 1-for-25 reverse stock split Seeking Alpha’s Quant Rating on Aeglea BioTherapeutics Historical ear...
2023-11-29 13:12:25 ET Summary Roche Holdings is a strong player in the pharmaceutical and diagnostics industry, with a focus on oncology and diagnostics, and has shown resilience during the COVID-19 pandemic. The company has demonstrated impressive financial growth, particularly ...
2023-11-22 16:31:44 ET More on Roche Holding Be Patient, Roche Is A Clear Buy At This Price Roche Holding AG (RHHBY) Q3 2023 Earnings Call Transcript Roche: Positive Readouts From Pipeline Nvidia in pact with Roche for AI-led drug development U.S. to ...
2023-11-21 09:27:03 ET More on Nvidia, Roche, etc. Nvidia Q3 Earnings Preview: Know The Risks And The Reward Nvidia: Smooth Sailing Nvidia Fiscal Q3 Earnings Preview: Big Wave Surfing 4 stocks to watch on Tuesday: Nvidia, Abercrombie & Fitch and more ...
- Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel therapies - - Multi-year research effort aims to optimize and accelerate each companyȁ...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Ltd ADR Company Name:
RHHBY Stock Symbol:
OTCMKTS Market:
Roche Holding Ltd ADR Website:
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
– Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) – – Safety data were consistent with the known safety profile for Susvimo in people...